Marc David Benathen - Jan 27, 2023 Form 4 Insider Report for LifeMD, Inc. (LFMD)

Role
Chief Financial Officer
Signature
/s/ Marc David Benathen
Stock symbol
LFMD
Transactions as of
Jan 27, 2023
Transactions value $
$0
Form type
4
Date filed
7/13/2023, 12:02 PM
Previous filing
Jan 28, 2022
Next filing
Mar 25, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFMD Common Stock Options Exercise $0 +25K +47.57% $0.00 77.6K Jan 27, 2023 Direct
transaction LFMD Common Stock Award +125K +161.18% 203K Jul 11, 2023 Direct F1
transaction LFMD Common Stock Options Exercise $0 +25K +12.34% $0.00 228K Jul 11, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFMD Employee Stock Option (Right to Buy) Disposed to Issuer -200K -100% 0 Jul 11, 2023 Common Stock 200K $21.20 Direct F1
transaction LFMD Restricted Stock Options Exercise $0 -25K -50% $0.00 25K Jan 27, 2023 Common Stock 25K Direct F2, F3
transaction LFMD Restricted Stock Options Exercise $0 -25K -100% $0.00* 0 Jul 11, 2023 Common Stock 25K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are being cancelled in exchange for 125,000 restricted shares, with 50,000 vesting on January 1, 2024 and 75,0000 vesting on January 1, 2025, and performance shares to be reported on settlement. In addition, vesting accelerated immediately on 25,000 restricted stock previously granted to Mr. Benathen on January 27, 2022. The option vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following February 4, 2021.
F2 Restricted stock converts into common stock on a one-for-one basis.
F3 Restricted stock vested on January 27, 2023.